Please Wait

Applying Filters...

Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector March 2025: Trump’s FDA overhaul spooks biotech stocks; Roche, AbbVie, Novo ink obesity drug deals

Stock Recap
#PipelineProspector

Dorzolamide HCl

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

48 API Suppliers, 14 USDMF, 13 CEP/COS, 5 JDMF, 7 EU WC, 13 KDMF, 12 NDC API, 30 Listed Suppliers, $ API Reference Price

INTERMEDIATES

9 Intermediate Suppliers

9 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

179 FDF Dossiers, 37 FDA Orange Book, 96 Europe, 17 Canada, 6 Australia, 8 South Africa, 15 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION/DROPS;OPHTHALMIC - EQ 2% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION/DROPS;OPHTHALMIC - EQ 2% BASE;EQ 0.5% BASE

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 13 SPI Pharma, 3 DKSH, 1 Faran Shimi Pharmaceutical, 1 Gangwal Healthcare, 1 Pfanstiehl, 4 Actylis, 1 BASF, 1 Finar, 2 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 2 Kerry, 2 Microlex e.U, 1 Pluviaendo, 3 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders, 11 Chewable & Orodispersible Aids, 10 Taste Masking, 10 Direct Compression, 7 Disintegrants & Superdisintegrants, 5 Parenteral, 5 Co-Processed Excipients, 4 Thickeners and Stabilizers, 3 Rheology Modifiers, 3 Solubilizers, 3 Topical, 3 Granulation, 2 Controlled & Modified Release

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 16 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 76 Regulatory FDF Prices

MARKET PLACE

16 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 4 USP, 4 JP, 6 Others

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
28/03/2025	Century Pharmaceuticals	India	CENTURY PHARMACEUTICALS LTD	34797	DORZOLAMIDE HYDROCHLORIDE USP	2020-07-22	Active	II	N/A
28/03/2025	Neuland Laboratories	India	NEULAND LABORATORIES LTD	21519	DORZOLAMIDE HYDROCHLORIDE FORM II USP	2008-04-09	Active	II	N/A

Contact us
to update this info

Dorzolamide HCl

Dorzolamide HCl

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

48 API Suppliers

14 USDMF

13 CEP/COS

5 JDMF

7 EU WC

13 KDMF

12 NDC API

30 Listed Suppliers

$ API Reference Price

INTERMEDIATES

9 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

179 FDF Dossiers

37 FDA Orange Book

96 Europe

17 Canada

6 Australia

8 South Africa

15 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION/DROPS;OPHTHALMIC - EQ 2% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION/DROPS;OPHTHALMIC - EQ 2% BASE;EQ 0.5% BASE

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

13 SPI Pharma

3 DKSH

1 Faran Shimi Pharmaceutical

1 Gangwal Healthcare

1 Pfanstiehl

4 Actylis

1 BASF

1 Finar

2 Gangwal Chemicals

1 Ingredion Pharma Solutions

2 Kerry

2 Microlex e.U

1 Pluviaendo

3 Roquette

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders

11 Chewable & Orodispersible Aids

10 Taste Masking

10 Direct Compression

7 Disintegrants & Superdisintegrants

5 Parenteral

5 Co-Processed Excipients

4 Thickeners and Stabilizers

3 Rheology Modifiers

3 Solubilizers

3 Topical

3 Granulation

2 Controlled & Modified Release

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

16 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions

76 Regulatory FDF Prices

MARKET PLACE

16 APIs

1 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM

4 USP

4 JP

6 Others

Filters

SOLUTION/DROPS;OPHTHALMIC - EQ 2% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons